MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$36,443K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Change in fair value of sermonix...
    • Maturities of available-for-sale...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of available-for-sale ...
    • Accounts payable and accrued lia...
    • Others

Cash Flow
2026-03-31
2025-12-31
Net loss
-32,948 -105,609
Non-cash consideration for acquired in-process research and development
NaN 67,659
Milestone liability change in fair value
-929 NaN
Change in fair value of sermonix pre-funded warrant
16,320 4,579
Stock-based compensation
662 6,102
Depreciation expense
231 972
Non-cash lease expense
74 273
Amortization of premiums and accretion of discounts on available-for-sale securities, net
260 329
Prepaid expenses and other current and long-term assets, net
396 -2,439
Accounts payable and accrued liabilities
-3,362 -21,342
Operating lease liability
-112 -414
Other long-term liabilities
-183 -59
Net cash used in operating activities
-20,903 -45,729
Purchases of available-for-sale securities
20,615 37,643
Maturities of available-for-sale securities
5,075 21,749
Net cash (used in) provided by investing activities
-15,540 -15,894
Proceeds from exercise of common stock options and issuance of common stock under employee stock purchase plan
NaN 37
Proceeds from pipe financing
NaN 89,991
Issuance costs from pipe financing
NaN 7,567
Net cash provided by financing activities
NaN 82,461
Net increase (decrease) in cash, cash equivalents and restricted cash
-36,443 20,838
Cash, cash equivalents and restricted cash, beginning of period
69,907 49,069
Cash, cash equivalents and restricted cash, end of period
33,464 69,907
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net increase(decrease) in cash, cash...-$36,443K Change in fair value ofsermonix pre-funded...$16,320K Stock-based compensation$662K Depreciation expense$231K Non-cash lease expense$74K Maturities ofavailable-for-sale securities$5,075K Net cash used inoperating activities-$20,903K Net cash (used in)provided by investing...-$15,540K Canceled cashflow$17,287K Canceled cashflow$5,075K Net loss-$32,948K Purchases ofavailable-for-sale securities$20,615K Accounts payable andaccrued liabilities-$3,362K Milestone liabilitychange in fair value-$929K Prepaid expenses andother current and...$396K Amortization of premiums andaccretion of discounts on...$260K Other long-termliabilities-$183K Operating lease liability-$112K

LeonaBio, Inc. (LONA)

LeonaBio, Inc. (LONA)